By Yantoultra Ngui

SINGAPORE (Reuters) -UltraGreen.ai Ltd, a medical imaging and fluorescence-guided surgery company, is aiming to raise about $400 million in a Singapore initial public offering at $1.45 per share, according to a term sheet reviewed by Reuters on Wednesday.

The company, which develops fluorescence-guided surgery technology and supplies indocyanine green (ICG) dyes, plans to list on the Singapore Exchange Mainboard on Dec. 3. It will report in U.S. dollars.

The company is building an AI-powered surgical intelligence platform, according to its website.

At the offer price, UltraGreen.ai would debut with a market capitalisation of about $1.6 billion on 1.103 billion shares on issue.

Singapore tops Southeast Asia’s IPO market with nine deals raising about US$1.6 billion so

See Full Page